Trial reportInternational urology and nephrology2026
Application study of pressure- and volume-controllable balloon in direct visualisation interstitial cystitis dilation surgery.
Trial report in International urology and nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Reassessing finerenone's role in IgA nephropathy: methodological and clinical considerations.International urology and nephrology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to evaluate the efficacy and safety of pressure- and volume-controlled balloon dilation in the treatment of interstitial cystitis/bladder pain syndrome (IC/BPS) and to compare it with traditional bladder hydrodistension to explore a superior therapeutic approach.
methodsA prospective randomised-controlled trial was conducted, enrolling 50 women with IC/BPS aged 52-77 years, treated between July 2013 and June 2023. Patients were randomly assigned to a pressure- and volume-controlled balloon dilation group (experimental group, n = 25) or a traditional bladder hydrodistension group (control group, n = 25). The primary outcome measures included interstitial cystitis symptom index and interstitial cystitis problem index (ICSI/ICPI) scores, pelvic pain and urinary frequency (PUF) scores, bladder capacity, nocturnal urination frequency, maximum voided volume, and postoperative complications (bleeding and bladder rupture). Statistical analyses were performed using t tests, Wilcoxon rank-sum tests, and Chi-square tests, with P < 0.05 indicating statistical significance.
resultsAt 6 months post-treatment, the experimental group showed significantly lower ICSI/ICPI scores than the control group (P < 0.05). The experimental group also exhibited significantly lower PUF scores at all time points (P < 0.05). Under non-anaesthetic conditions, the experimental group demonstrated significantly greater bladder capacity (P < 0.05), whereas no significant difference was observed under anaesthetic conditions (P > 0.05). The experimental group experienced significantly fewer episodes of nocturnal urination from 2 weeks to 6 months post-treatment (P < 0.05).
conclusionPressure- and volume-controlled balloon dilation demonstrated superior efficacy in alleviating IC/BPS symptoms and improving bladder function compared with traditional hydrodistension. Additionally, it was associated with a lower complication rate, offering a safer and more effective therapeutic option for patients with IC/BPS. CLINICAL
trial registrationID:ISRCTN25030604, https://www.isrctn.com/ISRCTN25030604.
Indexed as
Identifiers
40818007What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.